Publikationsliste Claudia Götz

Transcription

1 Publikationsliste Claudia Götz 1. Reinhard,B., Götz, C., and Faillard, H.: Synthesis of N-Acetyl-9-Oacetylneuraminic acid α-p-aminophenylthioketoside and its application as ligand in the affinity chromatography of a lectin with preferential affinity to O-acetylated sialic acids. Biol.Chem. Hoppe-Seyler 373: , Götz,C. and Montenarh,M. p53: DNA-damage, DNA repair and apoptosis. Rev. Physiol. Biochem. Pharmacol. 127: 65-95, Götz,C. and Montenarh,M. p53 and its implication in apoptosis. Int. J. Oncol. 6: , Götz,C., Koenig,M.G., Issinger,O.-G. and Montenarh,M. A protein kinase CK2 related kinase is tightly associated with SV40 large T antigen. Eur. J. Biochem. 233: , Götz,C., Wagner,P., Issinger,O.-G. and Montenarh,M. p21 WAF1/CIP1 interacts with protein kinase CK2. Oncogene 13: , Götz,C., Scholtes,P. and Montenarh,M. Characterization of the interaction between protein kinase CK2 and the C-terminus of p53. Eur. J. Cell Biol. 72: Guerra,B., Götz,C., Wagner,P., Montenarh,M. and Issinger,O.-G. The carboxy terminus of p53 mimicks the polylysine effect of protein kinase CK2- catalyzed MDM2 phosphorylation. Oncogene 14: , Montenarh,M. and Götz,C. p53 autoantibodies and human malignancies. Cancer Molec. Biol. 4: , 1997.

2 9. Montenarh,M. and Götz,C. p53 Autoantikörper bei Tumorerkrankungen: Wegweisende Marker. Münch. med. Wschr. 139: , Götz,C., Kartarius,S., Scholtes,P. and Montenarh,M. In vivo studies of the interaction between protein kinase CK2 and p21 WAF1/CIP1. Cancer Molec. Biol. 5: , Rief,N., Waschow,C., Nastainczyk,W., Montenarh,M. and Götz,C. Production and characterization of a rabbit monoclonal antibody against human CDC25C phosphatase. Hybridoma 17: , Wagner,P., Fuchs,A., Nastainczyk,W., Götz,C. and Montenarh,M. Fine mapping and regulation of the association of p53 and p34 cdc2. Oncogene 16: , Götz,C., Kartarius,S., Scholtes,P., Nastainczyk,W. and Montenarh,M. Identification of a CK2 phosphorylation site in mdm2. Eur. J. Biochem. 266: , Götz,C., Scholtes,P., Schuster,N., Prowald,A., Nastainczyk,W. and Montenarh,M. Protein kinase CK2 binds to a multi-protein binding domain of the growth suppressor protein p53. Mol. Cell. Biochem. 191: , Götz,C., Kartarius,S., Scholtes,P. and Montenarh,M. Binding domain of p21 WAF1/CIP1 on the polypeptide chain of the protein kinase CK2 β- subunit. Biochem. Biophys. Res. Commun. 268: , Rief,N., Herges,H., Prowald,A., Götz,C. and Montenarh,M. Binding of the growth suppressor p53 protein to the cell cycle regulator phosphatase cdc25c. Int. J. Oncol. 17: ,

3 17. Ababneh,M., Götz,C. and Montenarh,M. Downregulation of the cdc2/cyclin B protein kinase activity by binding of p53 to p34 cdc2. Biochem. Biophys. Res. Commun. 283: , Schuster,N., Götz,C., Faust,M., Schneider,E., Prowald,A., Jungbluth,A. and Montenarh,M. Wild-type p53 inhibits protein kinase CK2 activity. J. Cell. Biochem. 81: , Lensch,R., Götz,C., Andres,C., Bex,A., Lehmann,J., Zwergel,T., Unteregger,G., Kamradt,J., Stoeckle,M. and Wullich,B. Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude mice. Int. J. Oncol. 21: , Faust,M., Günther,J., Morgenstern,E., Montenarh,M. and Götz,C. Specific localization of the catalytic subunits of protein kinase CK2 at the centrosomes. Cell. Mol. Life Sci. 59: , Hessenauer,A., Montenarh,M. and Götz,C. Inhibition of CK2 activity provokes different responses in hormone-sensitive and hormone-refractory prostate cancer cells. Int. J. Oncol. 22: , Facchin,S., Lopreiato,R., Ruzzene,M., Marin,O., Götz,C., Sartori,G., Montenarh,M., Carignani,G. and Pinna,L.A. Functional conservation within a primordal protein kinase family:yeast pid/bud32 and human PRPK display interchangeable roles. FEBS Lett. 549: 63-66, Schwindling,S.L., Noll,A., Montenarh,M. and Götz,C. Mutation of a CK2 phosphorylation site in cdc25c impairs importin α/β binding and results in cytoplasmic retention. Oncogene 23: ,

4 24. Götz,C., Kartarius,S., Schetting,S. and Montenarh,M. Immunologically defined subclasses of the protein kinase CK2β-subunit in prostate carcinoma cell lines. Mol. Cell. Biochem. 274: , Götz,C., Kartarius,S., Schwär,G. and Montenarh,M. Phosphorylation of mdm2 at serine 269 impairs its interaction with the retinoblastoma protein. Int. J. Oncol. 26: , Touma,R., Kartarius,S., Harlozinska,A., Götz,C. and Montenarh,M. Growth inhibition and apoptosis induction in ovarian cancer cells. Int. J. Oncol. 29: , Busch,C., Barton,O., Morgenstern,E., Günther,J., Noll,A., Götz,C. and Montenarh,M. Protein phosphatase cdc25c is located within centrosomes. Int. J. Biochem. Cell Biol. 39: , Götz,C., Bachmann,C. and Montenarh,M. Inhibition of protein kinase CK2 leads to a modulation of androgen receptor dependent transcription in prostate cancer cells. The Prostate 67: , Ölgen, S., Götz, C., and Jose, J.: Synthesis and biological evaluation of 3- (substituted-benzylidene)-1,3-dihydro-indolin derivatives as human protein kinase CK2 and p60(c-src) tyrosine kinase inhibitors. Biol. Pharm. Bull. 30: , Ruppenthal,S.L., Noll,A., Götz,C. and Montenarh,M. Interference between p53 and cdc25c in cell cycle regulation. Int. J. Oncol. 31: ,

5 31. Dörr,J., Kartarius,S., Götz,C. and Montenarh,M. Contribution of the individual subunits of protein kinase CK2 and of hprp3p to the splicing process. Mol. Cell Biochem. 316: , Lehnert,S., Götz,C. and Montenarh,M. Protein kinase CK2 interacts with the splicing factor hprp3p. Oncogene 27: , Schäfer,B., Götz,C., Dudek,J., Hessenauer,A., Matti,U. and Montenarh,M. KIF5C, a new binding partner for protein kinase CK2 with a preference for CK2α'. Cell Mol. Life Sci. 66: , Schäfer,B., Götz,C. and Montenarh,M. The kinesin I family member KIF5C is a novel substrate for protein kinase CK2. Biochem. Biophys. Res. Commun. 375: , Schneider,C.C., Hessenauer,A., Götz,C. and Montenarh,M. DMAT:an inhibitor of protein kinase CK2 induces reactive oxygen species and DNA double strand breaks. Oncol. Rep. 21: , Götz, C., Müller A., Montenarh, M., Zimmermann, R., and Dudek, J.: The ER-membrane resident Hsp40 Erj1 is a novel substrate for protein kinase CK2. Biochem. Biophys.Res. Comm. 388: , Schneider,C.C., Hessenauer,A., Montenarh,M. and Götz,C. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2. Prostate 70: (2010). 38. Gratz A, Götz C, José J. A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease. J Enzyme Inhib. Med. Chem. 25:234-9 (2010) 5

6 39. Gratz A., Götz C., and José J. A CE-based assay for human protein kinase CK2 activity measurement and inhibitor screening. Electrophoresis 31: (2010). 40. Meng R., Al-Quobaili F., Müller I., Götz C., Thiel G., and Montenarh M. CK2 phosphorylation of Pdx-1 regulates its transcription factor activity. Cell. Mol. Life Sci. 67(14): (2010) 41. Ampofo E., Kietzmann T., Zimmer A., Jakupovic M., Montenarh M. and Götz C. Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1α mediated transcription: Int.J.Biochem.Cell Biol. 42: (2010) 42. Hessenauer A., Schneider C.C., Götz C., and Montenarh M. CK2 inhibition induces apoptosis via the ER stress response. Cellular Signalling 23: (2011). 43. Meng R., Götz, C., and Montenarh M. The role of protein kinase CK2 in the regulation of the insulin production of pancreatic islet cells. Biochem. Biophys. Res. Comm. 401: (2010). 6